RNA Therapeutics in Heart Failure

Area of Science:

• Biochemistry
• Molecular Biology
• Cardiovascular Medicine

Background:

• Heart failure (HF) pathogenesis involves complex molecular pathways.
• Current HF treatments have limitations in addressing underlying molecular mechanisms.
• RNA-based therapeutics offer novel strategies for molecularly targeted interventions.

Purpose of the Study:

• To review RNA-based therapeutics for heart failure (HF).
• To detail mechanisms and applications of RNA therapeutics in HF treatment.
• To identify novel therapeutic targets for HF.

Main Methods:

• Review of preclinical studies on RNA therapeutics in HF.
• Analysis of RNA therapeutic mechanisms targeting HF pathways.
• Exploration of pathological processes in HF amenable to RNA-based interventions.

Main Results:

• RNA therapeutics can modulate key HF pathological processes like calcium handling, fibrosis, oxidative stress, and inflammation.
• Preclinical studies demonstrate the potential of siRNAs, ASOs, and mRNAs in HF models.
• Novel therapeutic targets for HF amenable to RNA-based modulation have been identified.

Conclusions:

• RNA therapeutics represent a promising next-generation treatment strategy for HF.
• These therapies offer potential for more precise and personalized HF interventions.
• RNA-based approaches may help reverse disease progression in HF patients.